Results 51 to 60 of about 221,224 (62)

KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

Cancer Cell, 2019
Michael Overman, Jianhua Zhang, Di Zhao   +2 more
exaly  

Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase

Cancer Cell, 2018
Tina Cowan, Anna Scott, Davide Ruggero   +2 more
exaly  

Targeting the untargetable KRAS in cancer therapy

Acta Pharmaceutica Sinica B, 2019

exaly  

Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer

Annals of Oncology, 2016
Giuseppe Giaccone, K L Reckamp, L A Doyle   +2 more
exaly  

Ground beetles (Carabidae) from slopes of Macošská stráň and Vilémovická stráň (Protected landscape area of Moravský kras, Czech Republic)

Acta Universitatis Agriculturae Et Silviculturae Mendelianae Brunensis, 2014
Vladimir Hula, Pavla Stastna
exaly  

A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers

Cancer Cell
Xiufeng Pang, Xinyi Shi, Guizhen Zhou
exaly  

Differential Effector Engagement by Oncogenic KRAS

Cell Reports, 2018
Ji Luo, Ellen Murchie, Arnaud Amzallag   +2 more
exaly  

KRAS Alleles: The Devil Is in the Detail

Trends in Cancer, 2017
Kevin Haigis
exaly  

KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism

Cancer Cell, 2018
Kenneth H Pearce, Haiyong Han, Prson Gautam   +2 more
exaly  

Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial

Annals of Oncology, 2015
Roberto Labianca, Mirko Marabese, Valter Torri   +2 more
exaly